Venarus tab. p / o captivity. 500 mg # 30

Amount in a package

thirty

Dosage form

pills

Manufacturer

Obolenskoe FP, Russia

Structure

Active ingredients: diosmina - 0.45 g, hesperidin - 0.05 g.

Excipients (core): gelatin, magnesium stearate, microcrystalline cellulose, starch, sodium glycolate, talc.

Excipients (shell): polyethylene glycol 6000, magnesium stearate, hydroxypropyl methylcellulose, sodium lauryl sulfate, titanium dioxide, iron oxide red, iron oxide yellow.

pharmachologic effect

Pharmacodynamics

It has an angioprotective and venotonic effect.

Reduces the elasticity of veins, increases their tone and reduces venous congestion

reduces the permeability, fragility of capillaries and increases their resistance

improves microcirculation and lymph drainage.

With systematic use, it reduces the severity of clinical manifestations of chronic venous insufficiency of the lower extremities of an organic and functional nature.

Pharmacokinetics

The main excretion of the drug occurs in the feces.

With urine, on average, about 14% of the taken amount of the drug is excreted.

The half-life is 11 hours.

The drug undergoes active metabolism, as evidenced by the presence of phenolic acids in the urine.

Indications

Venous insufficiency of the lower extremities of a functional and organic nature (feeling of heaviness in the legs, pain, convulsions, trophic disorders).

Acute and chronic hemorrhoids.

Application during pregnancy and lactation

Pregnancy

Animal experiments have not revealed teratogenic effects.

Until now, there have been no reports of any side effects when using the drug by pregnant women.

Breastfeeding period

Due to the lack of data on the excretion of the drug into breast milk, it is not recommended for lactating women to take the drug.

Contraindications

Hypersensitivity to active ingredients or excipients that make up the drug.

It is not recommended to take the drug for lactating women.

Side effects

The incidence of adverse reactions is presented as follows:

Very often (? 1/10 cases).

Often (? 1/100 and < 1/10 cases).

Uncommon (? 1/1000 and < 1/100 cases).

Rarely (? 1/10000 and < 1/1000 cases).

Very rare (< 1/10000 cases).

Adverse reactions, the frequency of which is not possible to estimate from the available data, have the designation frequency is unknown."

From the side of the central nervous system: rarely - dizziness, headache, general malaise

frequency unknown - convulsions.

From the gastrointestinal tract: often - diarrhea, dyspepsia, nausea, vomiting

infrequently - colitis

frequency unknown - abdominal pain.

From the respiratory system, chest and mediastinal organs: frequency unknown - sore throat, chest pain.

From the side of the skin: rarely - rash, itching, urticaria

frequency is unknown - allergic dermatitis, hyperemia, isolated edema of the face, lips, eyelids, in exceptional cases, angioedema.

If any of the adverse reactions indicated in the instructions are aggravated, or you notice other adverse reactions that are not indicated in the instructions, inform your doctor.

Interaction

Not noted.

The attending physician should be informed about all medications taken.

How to take, course of administration and dosage

30 pcs.

50 mg + 450 mg.

Overdose

Overdose cases have not been described.

In case of drug overdose, seek medical attention immediately.

Special instructions

In case of exacerbation of hemorrhoids, the appointment of this drug does not replace the specific treatment of other anal disorders.

The duration of treatment should not exceed the time specified in the section "Dosage and Administration".

In the event that the symptoms do not disappear after the recommended course of therapy, a proctological examination should be carried out and the therapy used should be reviewed.

In the presence of disorders of venous circulation, the maximum effect of treatment is provided by a combination of therapy with a healthy (balanced) lifestyle: it is advisable to avoid long exposure to the sun, prolonged stay on the legs, and also to reduce excess body weight.

Hiking and, in some cases, wearing special stockings can improve blood circulation.

Impact on the ability to drive vehicles and other mechanisms that require increased concentration

Does not affect.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 ° C

Shelf life

2 years

Active substance

Hesperidin, Diosmin

Terms of dispensing from pharmacies

Without recipe

Name ENG

VENARUS

Clinical and pharmacological group

Venotonic drug.

ATX code

Diosmin in combination with other drugs

Dosage

50mg + 450mg

Structure

1 tablet contains: active ingredients: hesperidin (in terms of 100% substance) 100 mg, diosmin (in terms of 100% substance) 900 mg

excipients: microcrystalline cellulose 124 mg, sodium carboxymethyl starch (sodium starch glycolate) 54 mg, gelatin 62 mg, talc 12 mg, magnesium stearate 8 mg

excipients for the shell: hypromellose (hydroxypropyl methylcellulose 41.4 mg, macrogol 6000 (polyethylene glycol 6000) 6.76 mg, sodium lauryl sulfate 0.2 mg, magnesium stearate 2.48 mg, titanium dioxide 7.88 mg, iron oxide red 0, 6 mg, iron oxide yellow 0.68 mg.

Indications

Venarus is indicated for the treatment of symptoms of chronic venous disease (elimination and relief of symptoms).

Therapy for symptoms of venous lymphatic insufficiency:

- cramps of the lower extremities

- a feeling of heaviness and fullness in the legs

- pain

- "tiredness" of the legs.

Therapy of manifestations of venous-lymphatic insufficiency:

- edema of the lower extremities

- trophic changes in the skin and subcutaneous tissue

- venous trophic ulcers.

Symptomatic therapy of acute and chronic hemorrhoids.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 4 years

INN / Active ingredient

hesperidin, diosmin

Contraindications

Hypersensitivity to active ingredients or excipients that make up the drug.

It is not recommended to take the drug for lactating women.

Specifications

Category

Diseases of the veins

Scope of the drug

Heart, vessels, blood

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

thirty

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Obolenskoe FP

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Venotonic and venoprotective agent

Anatomical and therapeutic characteristics

C05CA53 Diosmin, in combination with other drugs

Dosage form

Film-coated tablets

Dosage (volume) of the substance in the preparation

450 mg + 50 mg

Expiration date in days

1460

Package weight, g

40

Mode of application

:

Inside. < br> < br> The recommended dose for venous-lymphatic insufficiency is 1 tablet per day, preferably in the morning, during meals. The risk on the tablet is intended solely for dividing in order to facilitate swallowing. < br> < br> The duration of the course of treatment can be several months (up to 12 months). In case of recurrence of symptoms, on the recommendation of a doctor, the course of treatment can be repeated. < br> < br> The recommended dose for acute hemorrhoids is 3 tablets per day (1 tablet in the morning, afternoon and evening) for 4 days, then 2 tablets per day (1 tablet in the morning and in the evening) for the next 3 days. < br> < br> The recommended dose for chronic hemorrhoids is 1 tablet per day.

Information on technical characteristics, delivery set, country of manufacture "